The effect of training on stress, anxiety,depression and self-efficacy in patients with pacemakers and cardiopulmonary defibrillator

The Comparison effect of Group Discussion and Video-Learning on Stress, anxiety,depression and self-efficacy in patients undergoing Pacemaker and Implantable- Cardioverter Defibrillator

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180120038453N1

Enrollment

105

Registered

2018-03-06

Start date

2017-09-11

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with pacemakers or cardiac implantation defibrillators. Presence of cardiac pacemaker

Interventions

Intervention 1: Intervention group 1: Learning by group discussion method : After calling patients and forming groups of 10-6, structured training was started during a 2-hour session at the conference

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients who are first implanted with pacemakers or cardiac defibrillators. They tended to participate in the study. Were in the age group of 18-75 years old. No psychiatric illness. The patient himself or his relatives were not members of the health team.

Exclusion criteria

Exclusion criteria: The patient died during the study. During the study, you should not cooperate with the researcher An unfortunate event that adds to anxiety and reduces self-efficacy.

Design outcomes

Primary

Measure	Time frame
Stress score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Stress questionnaire DASS21.;Anxiety score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Anxiety questionnaire DASS21.;Depression score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Depression questionnaire DASS21.;Self-efficacy scores in self-efficacy questionnaire for patients with pacemakers. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Self-efficacy questionnaire for patients with pacemakers.;Self-efficacy score in patients self-efficacy questionnaire has Cardiac implantable cardioverter defibrillator. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Self-efficacy questionnaire for patients with implantable cardioverter defibrillator.	—

Measure

Time frame

Stress score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Stress questionnaire DASS21.;Anxiety score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Anxiety questionnaire DASS21.;Depression score in the questionnaire DASS21. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Depression questionnaire DASS21.;Self-efficacy scores in self-efficacy questionnaire for patients with pacemakers. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Self-efficacy questionnaire for patients with pacemakers.;Self-efficacy score in patients self-efficacy questionnaire has Cardiac implantable cardioverter defibrillator. Timepoint: At the beginning of the study (before the training) and three weeks after the training. Method of measurement: Self-efficacy questionnaire for patients with implantable cardioverter defibrillator.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAllahyar Golabchi

Kashan University of Medical Sciences

s.sokoutmedical89@gmail.com+98 31 5554 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026